Consensus on treatment goals in hereditary angioedema: A global Delphi initiative

Marcus Maurer; Emel Aygören‐Pürsün; Aleena Banerji; Jonathan A. Bernstein; Henrik Balle Boysen; Paula J. Busse; Anette Bygum; Teresa Caballero; Anthony J. Castaldo; Sandra C. Christiansen; Timothy Craig; Henriette Farkas; Anete Sevciovic Grumach; Michihiro Hide; Constance H. Katelaris; H. Henry Li; Hilary Longhurst; William R. Lumry; Markus Magerl; Inmaculada Martinez‐Saguer; Marc A. Riedl; Yuxiang Zhi; Bruce L. Zuraw

doi:10.1016/j.jaci.2021.05.016

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The ultimate goal for HAE treatment is to achieve no angioedema attacks. The availability of improved treatments and disease management over the last decade now makes complete control of HAE a realistic possibility for most patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Maurer et al. (2021) studied this question.

synapsesocial.com/papers/69dc58025e1d727a1a274994 https://doi.org/10.1016/j.jaci.2021.05.016

View Full Paper

Ask AI

Bookmark

Share

Consensus on treatment goals in hereditary angioedema: A global Delphi initiative

Ask about this paper

Abstract

Discussion

Cite This Study

Consensus on treatment goals in hereditary angioedema: A global Delphi initiative

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading